Aurinia Pharmaceuticals - AUPH Operating Margin

Aurinia Pharma (AUPH) - corporate logo

Aurinia Pharmaceuticals (AUPH) relies on the success of Lupkynis, which ensures high profitability. However, geopolitical risks and logistics disruptions are hindering clinical trials, creating pressure on earnings. The estimated operating margin illustrates this volatility, where the 44.80 metric serves as the target level. Moving forward, management's focus on growing commercial revenues will determine the recovery dynamics of the share price.

auriniapharma.com (AUPH): Return on Sales by Operating Profit from 07/04/2022 to 11/20/2026

Analytical breakdowns and data insights for company Aurinia Pharmaceuticals Inc. (AUPH)

- price and consensus price forecast:
Fundamental company valuation:AUPH, Aurinia Pharmaceuticals Inc.
Finished products of auriniapharma.com

The indicator is calculated as the ratio of operating profit to revenue, excluding the impact of debt load and tax obligations. This metric determines the actual efficiency of business processes by stripping away one-off speculative factors. For Aurinia Pharmaceuticals (AUPH), this parameter reflects the commercial department's ability to monetize developments to fund staff bonuses. Analyzing the operating profit margin allows for an assessment of the stability of human capital. This chart's dynamics confirm the company's underlying profitability.

Who Aurinia Pharmaceuticals competes with

ARGX (argenx N.V.) - Operating Margin|Operating Return on Sales BioNTech Pharma BNTX|Operating Sales Margin ABVX (ABIVAX)|Operating Margin ADMA Biologics, Inc. (ADMA)|Operating Margin PTGX (protagonist-inc.com)|IMVT: Return on Sales by Operating Profit|KNSA - Operating Profitability|GRFS: Operating Profitability|ADPT (Adaptive Biotechnologies) - Operating Sales Margin|Return on Sales by Operating Profit CLDX|Operating Sales Margin BCRX|Operating Return on Sales Vera Therapeutics Inc VERA|Operating Sales Margin DNTH (Dianthus Pharma)|Profitability of Operations Pharvaris N.V.|AbCellera Biologics Inc - Operating Sales Margin|Tourmaline Bio (TRML) - Operating Return on Sales|PGEN - Operating Profitability|Operating Profit Rate PHAR (Pharming Group NV)|NKTR: Operating Margin|Upstream Bio Corp - Operating Profit Rate|Operating Profitability Zenas Biopharma Inc|Immunome, Inc. (IMNM) - Profitability of Operations|Operating Margin GOSS|Operating Sales Margin KalVista Pharmaceuticals, Inc. KALV|Operating Profitability Septerna SEPN|Pieris Pharmaceuticals (PVLA) - Operating Return on Sales|SVRA - Operating Profitability|Rigel Pharmaceuticals - Operating Profit Ratio|AnaptysBio Corp (ANAB) - Operating Profitability|ATXS - Profitability of Operations|Operating Profitability enGene Holdings Inc.|RAPT: Operating Profit Rate|Operating Margin JBIO|Operating Sales Margin aclaristx.com ACRS|Operating Profitability Kyverna Therapeutics Inc. KYTX|Tiziana Life Sciences Ltd. (TLSA) - Operating Return on Sales|Cabaletta Bio, Inc - Operating Margin|Operating Return on Sales Ventyx Biosciences|THTX (theratech.com) - Operating Sales Margin|Operating Sales Margin Avalo Therapeutics, Inc|ELDN (Eledon Pharmaceuticals, Inc) - Operating Margin|Operating Return on Sales Agenus Inc. AGEN|Operating Sales Margin CLYM (Climb Bio, Inc.)|ZURA (Zura Bio Ltd) - Operating Profit Rate|Operating Profitability atyrpharma.com ATYR|Operating Margin Adagene Corp ADAG|IMA - Operating Profitability|Operating Profit Rate STTK (Shattuck Labs)|EQ: Operating Margin|Connect Biopharma (CNTB) - Operating Margin|Operating Profitability Immunic|Operating Margin atarabio.com|Operating Margin IFRX|Operating Margin X4 Pharma (XFOR)|Operating Margin ACET (adicetbio.com)|Operating Margin Celularity Inc. CELU|INMB - Operating Profitability|Operating Profit Rate BRNS (Barinthus Biotherapeutics)|KZR (kezarlifesciences.com) - Operating Sales Margin|Operating Sales Margin SAB Biotherapeutics Inc.|Operating Sales Margin AKTX|Operating Sales Margin enlivex.com (ENLV)|Operating Profitability Q32 Bio Inc. (QTTB)|GeoVax Labs, Inc. (GOVX) - Operating Profitability Margin|Operating Margin EDSA (Edesa Biotech Corp)|Profitability of Operations iBio (IBIO)|CARM - Operating Profitability|XTL Biopharmaceuticals (XTLB) - Operating Sales Margin|BOLT: Operating Margin|Operating Sales Margin HCW Biologics Inc.|Operating Profitability Aptevo|Return on Sales by Operating Profit AIM (AIM ImmunoTech, Inc.)|Operating Margin ADTX|Profitability of Operations GRI Bio Corp|Operating Margin XRTX (XORTX Therapeutics Inc)|Vyome Holdings (HIND) - Operating Return on Sales|Revelation Biosciences Corp - Operating Margin|INDP (Indaptus Therapeutics, Inc.) - Return on Sales by Operating Profit|SCNI: Operating Margin|CALI - Profitability of Operations|AFMD (Affimed N.V.) - Operating Margin|Operating Profitability ALLK|Operating Sales Margin HOOK (HOOKIPA Pharma, Inc.)|IGMS - Operating Return on Sales|Operating Profitability iTeos ITOS|Ocean Bio - Operating Profitability|TC BioPharm Ltd - Operating Margin|Operating Return on Sales thirdharmonicbio.com